Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO · BSE: 524518 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹59.72
Market cap: ₹128.8 Cr
Revenue (annual): ₹23.73 Cr
Net profit (annual): ₹-16.93 Cr
P/E (TTM): -9.1×Sector 47.3×
Promoter holding: 72.74%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Price Movement Clarification 2 Board Meeting Date 2 Other Announcement 1 Merger & Restructuring 1 Legal & Regulatory 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

28 Jul 2026 10:49 IST BSE

Board Meeting Date

Krebs Biochemicals & Industries Board Meeting Date

Krebs Biochemicals & Industries has scheduled a board meeting for August 6, 2026. The board will consider and adopt the unaudited Q1 results for June 30, 2026.

Read the filing ↗

7 May 2026 15:02 IST BSE

Board Meeting Date

Krebs Biochemicals & Industries Board Meeting Date

Krebs Biochemicals & Industries Limited has scheduled a Board Meeting for May 21, 2026. The board will consider and adopt the audited financial results for the quarter and year ended March 31, 2026. Consequently, the trading window for company insiders remains closed until 48 hours after the result declaration.

Read the filing ↗